Skip to content
Disclosery

DAFNA Capital Management LLC

Follow

13F filer, CIK 1389933, LOS ANGELES, CA

DAFNA Capital Management LLC reported $524,358,409 across 88 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-14. Its ten largest share positions make up 56.21% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001389933-26-000006

Period
2026-06-30
Reported value
$524M
Holdings
88
Top 10 weight
56.21%
New
17
Sold out
12

Largest buys vs the previous quarter

SecurityShares changeApprox. value
ASNDnew+48,469$12.9M
DNLIadded+420,514$10.8M
NKTRadded+153,202$10.7M
PODDadded+51,000$7.76M
EWTXadded+114,583$4.66M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
DAWNexited-978,463-$21M
XBIreduced-122,000-$19.3M
BHVNreduced-708,142-$10.5M
MBXreduced-163,656-$9.03M
CMPSreduced-406,930-$5.76M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2026

Share positions as resolved from 13F-HR 0001389933-26-000006, largest first. % of portfolio is the value over $524,358,409, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 517,994 shares; 2024Q4: 631,176 shares; 2025Q1: 656,176 shares; 2025Q2: 677,176 shares; 2025Q3: 657,176 shares; 2025Q4: 604,514 shares; 2026Q1: 580,678 shares; 2026Q2: 562,630 shares 562,630$105M20.09%-18,048Timeline
XBISPDR SERIES TRUSTQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 401,505 shares; 2024Q4: 397,505 shares; 2025Q1: 404,505 shares; 2025Q2: 415,505 shares; 2025Q3: 401,505 shares; 2025Q4: 336,505 shares; 2026Q1: 318,505 shares; 2026Q2: 196,505 shares 196,505$31.1M5.93%-122,000Timeline
CMPSCOMPASS PATHWAYS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 243,210 shares; 2024Q4: 243,210 shares; 2025Q1: 711,046 shares; 2025Q2: 811,046 shares; 2025Q3: 811,046 shares; 2025Q4: 811,046 shares; 2026Q1: 2,418,882 shares; 2026Q2: 2,011,952 shares 2,011,952$28.5M5.43%-406,930Timeline
STXSSTEREOTAXIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 13,680,554 shares; 2024Q4: 13,680,554 shares; 2025Q1: 13,680,554 shares; 2025Q2: 13,680,554 shares; 2025Q3: 13,680,554 shares; 2025Q4: 13,680,554 shares; 2026Q1: 13,680,554 shares; 2026Q2: 13,680,554 shares 13,680,554$23.5M4.49%0Timeline
NKTRNEKTAR THERAPEUTICSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 10,000 shares; 2025Q3: 54,998 shares; 2025Q4: 74,998 shares; 2026Q1: 165,178 shares; 2026Q2: 318,380 shares 318,380$22.2M4.24%+153,202Timeline
DNLIDENALI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 127,900 shares; 2025Q2: 168,500 shares; 2025Q3: 168,500 shares; 2025Q4: 318,500 shares; 2026Q1: 318,500 shares; 2026Q2: 739,014 shares 739,014$19M3.62%+420,514Timeline
IDYAIDEAYA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 471,410 shares; 2024Q4: 498,827 shares; 2025Q1: 589,330 shares; 2025Q2: 619,090 shares; 2025Q3: 539,923 shares; 2025Q4: 506,740 shares; 2026Q1: 476,740 shares; 2026Q2: 497,240 shares 497,240$18.5M3.53%+20,500Timeline
ATRCATRICURE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 641,673 shares; 2024Q4: 641,673 shares; 2025Q1: 592,273 shares; 2025Q2: 592,273 shares; 2025Q3: 592,273 shares; 2025Q4: 597,431 shares; 2026Q1: 597,431 shares; 2026Q2: 597,431 shares 597,431$16.7M3.19%0Timeline
XENEXENON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 273,739 shares; 2024Q4: 273,739 shares; 2025Q1: 273,739 shares; 2025Q2: 287,939 shares; 2025Q3: 287,939 shares; 2025Q4: 287,939 shares; 2026Q1: 250,772 shares; 2026Q2: 250,772 shares 250,772$15.1M2.89%0Timeline
CYTKCYTOKINETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 398,100 shares; 2024Q4: 398,100 shares; 2025Q1: 398,100 shares; 2025Q2: 398,100 shares; 2025Q3: 394,940 shares; 2025Q4: 370,997 shares; 2026Q1: 217,497 shares; 2026Q2: 171,998 shares 171,998$14.7M2.79%-45,499Timeline
RCUSARCUS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 256,717 shares; 2024Q4: 254,217 shares; 2025Q1: 625,126 shares; 2025Q2: 627,626 shares; 2025Q3: 627,626 shares; 2025Q4: 431,329 shares; 2026Q1: 443,829 shares; 2026Q2: 441,829 shares 441,829$13.6M2.6%-2,000Timeline
ASNDASCENDIS PHARMA A/SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 48,469 shares 48,469$12.9M2.47%newTimeline
NBIXNEUROCRINE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 69,615 shares; 2024Q4: 71,615 shares; 2025Q1: 71,615 shares; 2025Q2: 70,615 shares; 2025Q3: 70,615 shares; 2025Q4: 70,615 shares; 2026Q1: 70,615 shares; 2026Q2: 57,769 shares 57,769$9.74M1.86%-12,846Timeline
AXGNAXOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 935,894 shares; 2024Q4: 846,882 shares; 2025Q1: 680,782 shares; 2025Q2: 741,782 shares; 2025Q3: 742,282 shares; 2025Q4: 476,826 shares; 2026Q1: 249,960 shares; 2026Q2: 208,960 shares 208,960$9.65M1.84%-41,000Timeline
PODDINSULET CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 15,900 shares; 2024Q4: 12,400 shares; 2025Q1: 11,900 shares; 2025Q2: 9,900 shares; 2025Q3: 6,870 shares; 2025Q4: 6,870 shares; 2026Q1: 10,870 shares; 2026Q2: 61,870 shares 61,870$9.42M1.8%+51,000Timeline
EWTXEDGEWISE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 227,906 shares; 2024Q4: 187,140 shares; 2025Q1: 183,140 shares; 2025Q2: 238,140 shares; 2025Q3: 213,736 shares; 2025Q4: 159,736 shares; 2026Q1: 112,236 shares; 2026Q2: 226,819 shares 226,819$9.22M1.76%+114,583Timeline
BCAXBICARA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 105,500 shares; 2025Q1: 212,001 shares; 2025Q2: 317,001 shares; 2025Q3: 317,001 shares; 2025Q4: 261,583 shares; 2026Q1: 421,733 shares; 2026Q2: 284,955 shares 284,955$8.46M1.61%-136,778Timeline
IBBISHARES TRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 102,500 shares; 2024Q4: 102,500 shares; 2025Q1: 102,500 shares; 2025Q2: 102,500 shares; 2025Q3: 102,500 shares; 2025Q4: 68,095 shares; 2026Q1: 62,095 shares; 2026Q2: 42,595 shares 42,595$8.1M1.54%-19,500Timeline
SNDXSYNDAX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 526,702 shares; 2024Q4: 542,002 shares; 2025Q1: 544,502 shares; 2025Q2: 543,602 shares; 2025Q3: 500,702 shares; 2025Q4: 277,855 shares; 2026Q1: 217,355 shares; 2026Q2: 335,255 shares 335,255$7.33M1.4%+117,900Timeline
MPLTMAPLIGHT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 143,764 shares; 2026Q1: 171,006 shares; 2026Q2: 171,006 shares 171,006$6.13M1.17%0Timeline
LRMRLARIMAR THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 494,274 shares; 2024Q4: 371,434 shares; 2025Q1: 371,434 shares; 2025Q2: 371,434 shares; 2025Q3: 1,027,764 shares; 2025Q4: 939,164 shares; 2026Q1: 2,029,164 shares; 2026Q2: 2,008,164 shares 2,008,164$6.12M1.17%-21,000Timeline
IPSCCENTURY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,704,232 shares; 2024Q4: 1,704,232 shares; 2025Q1: 1,704,232 shares; 2025Q2: 1,704,232 shares; 2025Q3: 1,704,232 shares; 2025Q4: 2,793,586 shares; 2026Q1: 2,434,353 shares; 2026Q2: 2,400,458 shares 2,400,458$5.88M1.12%-33,895Timeline
DXCMDEXCOM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 65,552 shares; 2024Q4: 65,552 shares; 2025Q1: 65,552 shares; 2025Q2: 65,552 shares; 2025Q3: 65,552 shares; 2025Q4: 88,279 shares; 2026Q1: 86,279 shares; 2026Q2: 86,279 shares 86,279$5.81M1.11%0Timeline
IMVTIMMUNOVANT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 51,996 shares; 2024Q4: 107,996 shares; 2025Q1: 169,996 shares; 2025Q2: 191,493 shares; 2025Q3: 191,493 shares; 2025Q4: 150,524 shares; 2026Q1: 150,524 shares; 2026Q2: 149,524 shares 149,524$5.76M1.1%-1,000Timeline
INGNINOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 208,790 shares; 2024Q4: 208,790 shares; 2025Q1: 458,065 shares; 2025Q2: 605,625 shares; 2025Q3: 605,625 shares; 2025Q4: 827,071 shares; 2026Q1: 845,179 shares; 2026Q2: 845,179 shares 845,179$5.45M1.04%0Timeline
TNDMTANDEM DIABETES CARE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 204,208 shares; 2024Q4: 223,208 shares; 2025Q1: 294,208 shares; 2025Q2: 294,208 shares; 2025Q3: 355,208 shares; 2025Q4: 355,208 shares; 2026Q1: 355,208 shares; 2026Q2: 355,208 shares 355,208$5.36M1.02%0Timeline
ALKSALKERMES PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 120,700 shares; 2024Q4: 120,700 shares; 2025Q1: 94,200 shares; 2025Q2: 103,748 shares; 2025Q3: 134,748 shares; 2025Q4: 130,248 shares; 2026Q1: 139,482 shares; 2026Q2: 101,266 shares 101,266$5.31M1.01%-38,216Timeline
STOKSTOKE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 207,427 shares; 2024Q4: 171,097 shares; 2025Q1: 443,998 shares; 2025Q2: 501,972 shares; 2025Q3: 169,791 shares; 2025Q4: 108,875 shares; 2026Q1: 130,875 shares; 2026Q2: 130,875 shares 130,875$4.28M0.82%0Timeline
ALLOALLOGENE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,050,118 shares; 2024Q4: 1,240,118 shares; 2025Q1: 1,380,118 shares; 2025Q2: 1,380,118 shares; 2025Q3: 1,380,118 shares; 2025Q4: 1,380,118 shares; 2026Q1: 1,370,118 shares; 2026Q2: 2,000,000 shares 2,000,000$4.16M0.79%+629,882Timeline
BCRXBIOCRYST PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 667,000 shares; 2024Q4: 667,000 shares; 2025Q1: 558,255 shares; 2025Q2: 218,255 shares; 2025Q3: 218,255 shares; 2025Q4: 418,255 shares; 2026Q1: 430,248 shares; 2026Q2: 400,248 shares 400,248$4M0.76%-30,000Timeline
LKFTLAKEFRONT BIOTHERAPEUTICS NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 130,175 shares; 2024Q4: 130,175 shares; 2025Q1: 130,175 shares; 2025Q2: 130,175 shares; 2025Q3: 130,175 shares; 2025Q4: 130,175 shares; 2026Q1: 130,175 shares; 2026Q2: 130,175 shares 130,175$3.9M0.74%0Timeline
KIDSORTHOPEDIATRICS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 95,659 shares; 2026Q2: 189,130 shares 189,130$3.62M0.69%+93,471Timeline
HELPCYBIN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 455,018 shares; 2026Q1: 498,361 shares; 2026Q2: 514,061 shares 514,061$3.4M0.65%+15,700Timeline
RAPPRAPPORT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 75,000 shares; 2025Q4: 75,000 shares; 2026Q1: 75,000 shares; 2026Q2: 75,000 shares 75,000$3.13M0.6%0Timeline
KYMRKYMERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 27,000 shares 27,000$3.1M0.59%newTimeline
PRQRPROQR THRAPEUTICS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 905,582 shares; 2024Q4: 1,567,561 shares; 2025Q1: 1,567,561 shares; 2025Q2: 1,567,561 shares; 2025Q3: 1,567,561 shares; 2025Q4: 1,567,561 shares; 2026Q1: 1,567,561 shares; 2026Q2: 1,530,361 shares 1,530,361$2.85M0.54%-37,200Timeline
NGNENEUROGENE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 7,775 shares; 2024Q4: 51,500 shares; 2025Q1: 51,500 shares; 2025Q2: 51,096 shares; 2025Q3: 30,375 shares; 2025Q4: 27,974 shares; 2026Q1: 56,635 shares; 2026Q2: 89,032 shares 89,032$2.8M0.53%+32,397Timeline
ANLADLAI NORTYE GROUP LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 239,553 shares 239,553$2.75M0.53%newTimeline
PRCTPROCEPT BIOROBOTICS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 3,000 shares; 2025Q3: not reported; 2025Q4: 120,000 shares; 2026Q1: 120,000 shares; 2026Q2: 120,000 shares 120,000$2.71M0.52%0Timeline
AQSTAQUESTIVE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 589,561 shares; 2024Q4: 127,000 shares; 2025Q1: 142,000 shares; 2025Q2: 142,000 shares; 2025Q3: 512,589 shares; 2025Q4: 375,915 shares; 2026Q1: 368,415 shares; 2026Q2: 645,915 shares 645,915$2.69M0.51%+277,500Timeline
CLDXCELLDEX THERAPEUTICS INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 24,518 shares; 2025Q4: 68,518 shares; 2026Q1: 68,518 shares; 2026Q2: 68,518 shares 68,518$2.55M0.49%0Timeline
GPCRSTRUCTURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 34,000 shares; 2024Q4: 35,500 shares; 2025Q1: 59,000 shares; 2025Q2: 59,000 shares; 2025Q3: 59,000 shares; 2025Q4: 37,000 shares; 2026Q1: 46,500 shares; 2026Q2: 46,500 shares 46,500$2.5M0.48%0Timeline
ALGNALIGN TECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 5,500 shares; 2025Q1: 11,000 shares; 2025Q2: 11,000 shares; 2025Q3: 11,000 shares; 2025Q4: 16,000 shares; 2026Q1: 15,000 shares; 2026Q2: 14,000 shares 14,000$2.36M0.45%-1,000Timeline
VKTXVIKING THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 125,616 shares; 2024Q4: 64,516 shares; 2025Q1: 64,516 shares; 2025Q2: 64,516 shares; 2025Q3: 64,516 shares; 2025Q4: 59,516 shares; 2026Q1: 59,516 shares; 2026Q2: 59,516 shares 59,516$2.32M0.44%0Timeline
NGENNERVGEN PHARMA CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,050,000 shares 1,050,000$2.16M0.41%newTimeline
BHVNBIOHAVEN LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 187,130 shares; 2024Q4: 220,235 shares; 2025Q1: 220,235 shares; 2025Q2: 235,235 shares; 2025Q3: 235,235 shares; 2025Q4: 955,235 shares; 2026Q1: 845,735 shares; 2026Q2: 137,593 shares 137,593$2.05M0.39%-708,142Timeline
MAZEMAZE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 35,000 shares; 2026Q2: 65,000 shares 65,000$1.94M0.37%+30,000Timeline
ALECALECTOR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 912,928 shares; 2024Q4: 912,928 shares; 2025Q1: 912,928 shares; 2025Q2: 912,928 shares; 2025Q3: 798,351 shares; 2025Q4: 908,351 shares; 2026Q1: 908,351 shares; 2026Q2: 908,351 shares 908,351$1.83M0.35%0Timeline
LXEOLEXEO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 250,583 shares; 2024Q4: 393,083 shares; 2025Q1: 378,083 shares; 2025Q2: 378,083 shares; 2025Q3: 358,083 shares; 2025Q4: 340,859 shares; 2026Q1: 377,059 shares; 2026Q2: 377,059 shares 377,059$1.76M0.33%0Timeline
PROFPROFOUND MED CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 285,710 shares; 2026Q1: 263,005 shares; 2026Q2: 260,360 shares 260,360$1.73M0.33%-2,645Timeline
RNAATRIUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 128,000 shares 128,000$1.72M0.33%newTimeline
ANNXANNEXON INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 272,812 shares; 2026Q1: 117,812 shares; 2026Q2: 297,812 shares 297,812$1.7M0.32%+180,000Timeline
CTMXCYTOMX THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 230,000 shares; 2026Q2: 438,407 shares 438,407$1.64M0.31%+208,407Timeline
RAREULTRAGENYX PHARMACEUTICAL INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 16,000 shares; 2026Q1: 61,100 shares; 2026Q2: 47,100 shares 47,100$1.57M0.3%-14,000Timeline
EPRXEUPRAXIA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 225,600 shares 225,600$1.49M0.28%newTimeline
DSGNDESIGN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 102,600 shares 102,600$1.48M0.28%newTimeline
FATEFATE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 550,000 shares; 2026Q1: 550,000 shares; 2026Q2: 525,000 shares 525,000$1.42M0.27%-25,000Timeline
MDWDMEDIWOUND LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 64,479 shares; 2024Q4: 64,479 shares; 2025Q1: 64,479 shares; 2025Q2: 64,479 shares; 2025Q3: 113,612 shares; 2025Q4: 113,612 shares; 2026Q1: 94,405 shares; 2026Q2: 94,405 shares 94,405$1.39M0.26%0Timeline
KURAKURA ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 408,368 shares; 2024Q4: 448,368 shares; 2025Q1: 463,368 shares; 2025Q2: 463,368 shares; 2025Q3: 463,368 shares; 2025Q4: 235,868 shares; 2026Q1: 235,868 shares; 2026Q2: 120,568 shares 120,568$1.32M0.25%-115,300Timeline
SPRYARS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 148,294 shares; 2024Q4: 88,790 shares; 2025Q1: 95,290 shares; 2025Q2: not reported; 2025Q3: 140,500 shares; 2025Q4: 190,065 shares; 2026Q1: 139,285 shares; 2026Q2: 164,285 shares 164,285$1.32M0.25%+25,000Timeline
MLYSMINERALYS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 146,500 shares; 2024Q4: 146,500 shares; 2025Q1: 309,200 shares; 2025Q2: 371,523 shares; 2025Q3: 83,490 shares; 2025Q4: 38,490 shares; 2026Q1: 38,490 shares; 2026Q2: 44,490 shares 44,490$1.2M0.23%+6,000Timeline
IMTXIMMATICS N.VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 145,000 shares; 2024Q4: 245,000 shares; 2025Q1: 245,000 shares; 2025Q2: 245,000 shares; 2025Q3: 235,000 shares; 2025Q4: 261,138 shares; 2026Q1: 225,860 shares; 2026Q2: 116,960 shares 116,960$1.18M0.23%-108,900Timeline
TELATELA BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 1,441,029 shares; 2025Q1: 1,441,029 shares; 2025Q2: 1,441,029 shares; 2025Q3: 1,441,029 shares; 2025Q4: 1,441,029 shares; 2026Q1: 1,441,029 shares; 2026Q2: 1,441,029 shares 1,441,029$1.08M0.21%0Timeline
PYPDPOLYPID LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 308,497 shares; 2024Q4: 291,273 shares; 2025Q1: 291,273 shares; 2025Q2: 207,900 shares; 2025Q3: 207,900 shares; 2025Q4: 207,900 shares; 2026Q1: 207,900 shares; 2026Q2: 207,900 shares 207,900$1.06M0.2%0Timeline
CRBPCORBUS PHARMACEUTICALS HLDGSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 107,773 shares 107,773$1.01M0.19%newTimeline
INSPINSPIRE MED SYS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 17,200 shares; 2025Q4: 8,600 shares; 2026Q1: 18,200 shares; 2026Q2: 18,200 shares 18,200$812K0.15%0Timeline
ACETADICET BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 93,812 shares; 2026Q1: 93,812 shares; 2026Q2: 93,812 shares 93,812$811K0.15%0Timeline
SPTXSEAPORT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 32,400 shares 32,400$704K0.13%newTimeline
MBXMBX BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 85,000 shares; 2025Q4: 165,265 shares; 2026Q1: 175,465 shares; 2026Q2: 11,809 shares 11,809$652K0.12%-163,656Timeline
BNTXBIONTECH SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 8,500 shares; 2024Q4: 8,500 shares; 2025Q1: 10,500 shares; 2025Q2: 7,000 shares; 2025Q3: 7,000 shares; 2025Q4: 7,000 shares; 2026Q1: 7,000 shares; 2026Q2: 7,000 shares 7,000$651K0.12%0Timeline
ARTVARTIVA BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 67,101 shares 67,101$651K0.12%newTimeline
PLRXPLIANT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 487,000 shares; 2026Q2: 487,000 shares 487,000$555K0.11%0Timeline
SCYXSCYNEXIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 135,868 shares 135,868$553K0.11%newTimeline
EDITEDITAS MEDICINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 170,470 shares 170,470$552K0.11%newTimeline
OBIOORCHESTRA BIOMED HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 363,636 shares; 2025Q4: 126,841 shares; 2026Q1: 126,841 shares; 2026Q2: 126,841 shares 126,841$547K0.1%0Timeline
FHTXFOGHORN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 37,664 shares; 2024Q4: 186,717 shares; 2025Q1: 304,752 shares; 2025Q2: 300,452 shares; 2025Q3: 126,859 shares; 2025Q4: 126,859 shares; 2026Q1: 111,859 shares; 2026Q2: 111,859 shares 111,859$546K0.1%0Timeline
ARAYACCURAY INC DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,222,358 shares; 2024Q4: 1,222,358 shares; 2025Q1: 1,222,358 shares; 2025Q2: 1,222,358 shares; 2025Q3: 1,222,358 shares; 2025Q4: 1,395,508 shares; 2026Q1: 1,680,508 shares; 2026Q2: 1,680,508 shares 1,680,508$433K0.08%0Timeline
QTTBQ32 BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 32,896 shares 32,896$419K0.08%newTimeline
NVCTNUVECTIS PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 20,000 shares 20,000$368K0.07%newTimeline
CGENCOMPUGEN LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 447,202 shares; 2024Q4: 447,202 shares; 2025Q1: 272,402 shares; 2025Q2: 272,402 shares; 2025Q3: 272,402 shares; 2025Q4: 272,402 shares; 2026Q1: 257,783 shares; 2026Q2: 168,232 shares 168,232$360K0.07%-89,551Timeline
IBIOIBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 193,638 shares; 2026Q2: 170,053 shares 170,053$298K0.06%-23,585Timeline
AUTLAUTOLUS THERAPEUTICS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 486,667 shares; 2024Q4: 586,667 shares; 2025Q1: 586,667 shares; 2025Q2: 425,616 shares; 2025Q3: 179,316 shares; 2025Q4: 179,316 shares; 2026Q1: 179,316 shares; 2026Q2: 179,316 shares 179,316$287K0.05%0Timeline
BCYCBICYCLE THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 122,200 shares; 2024Q4: 120,799 shares; 2025Q1: 80,799 shares; 2025Q2: 64,492 shares; 2025Q3: 64,492 shares; 2025Q4: 64,492 shares; 2026Q1: 64,492 shares; 2026Q2: 64,492 shares 64,492$273K0.05%0Timeline
TNYATENAYA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 47,319 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 300,000 shares 300,000$222K0.04%newTimeline
VRCAVERRICA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 173,451 shares; 2026Q1: 153,712 shares; 2026Q2: 23,750 shares 23,750$145K0.03%-129,962Timeline
ENGNENGENE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 74,650 shares 74,650$129K0.02%newTimeline
KARDKARDIGAN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 5,000 shares 5,000$119K0.02%newTimeline
ADCTADC THERAPEUTICS SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 204,081 shares; 2024Q4: 224,081 shares; 2025Q1: 224,081 shares; 2025Q2: 122,081 shares; 2025Q3: 122,081 shares; 2025Q4: 77,081 shares; 2026Q1: 72,081 shares; 2026Q2: 77,081 shares 77,081$82.5K0.02%+5,000Timeline

Sold out in Q2 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
DAWNDAY ONE BIOPHARMACEUTICALS I978,463$21Mshares
ASCENDIS PHARMA A/SASCENDIS PHARMA A/S4,000,000$5.92Mprincipal
KALVKALVISTA PHARMACEUTICALS INC267,402$5.38Mshares
ASNDASCENDIS PHARMA A/S23,177$5.3Mshares
FULCFULCRUM THERAPEUTICS INC205,000$1.57Mshares
ENGNENGENE HOLDINGS INC187,353$1.28Mshares
SCYXSCYNEXIS INC1,086,956$997Kshares
ORICORIC PHARMACEUTICALS INC98,724$945Kshares
ZBIOZENAS BIOPHARMA INC42,500$831Kshares
NAMSNEWAMSTERDAM PHARMA COMPANY20,000$640Kshares
KPTIKARYOPHARM THERAPEUTICS INC45,800$255Kshares
NMRANEUMORA THERAPEUTICS INC.70,000$136Kshares

How Q2 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001389933-26-000006 base2026-08-14acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0001389933-26-000006 Quarter ended 2026-06-302026-08-14acceptance time not in the bulk data set
13F-HR 0001389933-26-000004 Quarter ended 2026-03-312026-05-15acceptance time not in the bulk data set
13F-HR 0001389933-26-000002 Quarter ended 2025-12-312026-02-17acceptance time not in the bulk data set
13F-HR 0001389933-25-000008 Quarter ended 2025-09-302025-11-14acceptance time not in the bulk data set
13F-HR 0001389932-25-000011 Quarter ended 2025-06-302025-08-14acceptance time not in the bulk data set
13F-HR 0001389933-25-000002 Quarter ended 2025-03-312025-05-15acceptance time not in the bulk data set
13F-HR 0001389932-25-000004 Quarter ended 2024-12-312025-02-14acceptance time not in the bulk data set
13F-HR 0001389932-24-000020 Quarter ended 2024-09-302024-11-14acceptance time not in the bulk data set
13F-HR 0001389932-24-000016 Quarter ended 2024-06-302024-08-14acceptance time not in the bulk data set
13F-HR 0001389932-24-000012 Quarter ended 2024-03-312024-05-15acceptance time not in the bulk data set
13F-HR 0001389932-24-000004 Quarter ended 2023-12-312024-02-14acceptance time not in the bulk data set
13F-HR 0001389932-23-000010 Quarter ended 2023-09-302023-11-14acceptance time not in the bulk data set
13F-HR 0001389933-23-000008 Quarter ended 2023-06-302023-08-14acceptance time not in the bulk data set
13F-HR 0001389933-23-000006 Quarter ended 2023-03-312023-05-15acceptance time not in the bulk data set
13F-HR 0001389933-23-000002 Quarter ended 2022-12-312023-02-14acceptance time not in the bulk data set
13F-HR 0001389933-22-000010 Quarter ended 2022-09-302022-11-14acceptance time not in the bulk data set
13F-HR 0001389933-22-000008 Quarter ended 2022-06-302022-08-15acceptance time not in the bulk data set
13F-HR 0001389933-22-000006 Quarter ended 2022-03-312022-05-16acceptance time not in the bulk data set
13F-HR 0001389933-22-000002 Quarter ended 2021-12-312022-02-14acceptance time not in the bulk data set
13F-HR 0001389933-21-000011 Quarter ended 2021-09-302021-11-15acceptance time not in the bulk data set
13F-HR 0001389933-21-000009 Quarter ended 2021-06-302021-08-16acceptance time not in the bulk data set
13F-HR 0001389933-21-000007 Quarter ended 2021-03-312021-05-17acceptance time not in the bulk data set
13F-HR 0001389933-21-000004 Quarter ended 2020-12-312021-02-16acceptance time not in the bulk data set
13F-HR 0001389933-20-000010 Quarter ended 2020-09-302020-11-16acceptance time not in the bulk data set
13F-HR 0001389933-20-000008 Quarter ended 2020-06-302020-08-14acceptance time not in the bulk data set
13F-HR 0001389933-20-000006 Quarter ended 2020-03-312020-05-15acceptance time not in the bulk data set
13F-HR 0001389933-20-000004 Quarter ended 2019-12-312020-02-14acceptance time not in the bulk data set
13F-HR 0001389933-19-000010 Quarter ended 2019-09-302019-11-14acceptance time not in the bulk data set
13F-HR 0001389933-19-000008 Quarter ended 2019-06-302019-08-14acceptance time not in the bulk data set
13F-HR 0001389933-19-000006 Quarter ended 2019-03-312019-05-15acceptance time not in the bulk data set
13F-HR 0001389933-19-000002 Quarter ended 2018-12-312019-02-14acceptance time not in the bulk data set
13F-HR 0001389933-18-000012 Quarter ended 2018-09-302018-11-14acceptance time not in the bulk data set
13F-HR 0001389933-18-000010 Quarter ended 2018-06-302018-08-13acceptance time not in the bulk data set
13F-HR 0001389933-18-000008 Quarter ended 2018-03-312018-05-15acceptance time not in the bulk data set
13F-HR 0001389933-18-000002 Quarter ended 2017-12-312018-02-14acceptance time not in the bulk data set
13F-HR 0001389933-17-000025 Quarter ended 2017-09-302017-11-14acceptance time not in the bulk data set
13F-HR 0001389933-17-000023 Quarter ended 2017-06-302017-08-14acceptance time not in the bulk data set
13F-HR 0001389933-17-000018 Quarter ended 2017-03-312017-05-15acceptance time not in the bulk data set
13F-HR 0001389933-17-000014 Quarter ended 2016-12-312017-02-14acceptance time not in the bulk data set
13F-HR 0001389933-16-000037 Quarter ended 2016-09-302016-11-14acceptance time not in the bulk data set
13F-HR 0001389933-16-000031 Quarter ended 2016-06-302016-08-15acceptance time not in the bulk data set
13F-HR 0001389933-16-000029 Quarter ended 2016-03-312016-05-16acceptance time not in the bulk data set
13F-HR 0001389933-16-000022 Quarter ended 2015-12-312016-02-12acceptance time not in the bulk data set
13F-HR 0001389933-15-000019 Quarter ended 2015-09-302015-11-13acceptance time not in the bulk data set
13F-HR 0001389933-15-000016 Quarter ended 2015-06-302015-08-14acceptance time not in the bulk data set
13F-HR 0001389933-15-000013 Quarter ended 2015-03-312015-05-15acceptance time not in the bulk data set
13F-HR 0001389933-15-000009 Quarter ended 2014-12-312015-02-17acceptance time not in the bulk data set
13F-HR 0001389933-14-000012 Quarter ended 2014-09-302014-11-14acceptance time not in the bulk data set
13F-HR 0001389933-14-000010 Quarter ended 2014-06-302014-08-14acceptance time not in the bulk data set
13F-HR 0001389933-14-000008 Quarter ended 2014-03-312014-05-15acceptance time not in the bulk data set
13F-HR 0001389933-14-000001 Quarter ended 2013-12-312014-02-14acceptance time not in the bulk data set
13F-HR 0001389933-13-000012 Quarter ended 2013-09-302013-11-14acceptance time not in the bulk data set
13F-HR 0001389933-13-000010 Quarter ended 2013-06-302013-08-14acceptance time not in the bulk data set